World Politics Report
SEE OTHER BRANDS

Bringing you the latest news on politics

World Politics Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Politics Report.

Press releases published on July 17, 2025

U.S. Video Surveillance Market to Reach $18.06 Billion by 2030

U.S. Video Surveillance Market to Reach $18.06 Billion by 2030

Delray Beach, FL, July 17, 2025 (GLOBE NEWSWIRE) -- The report "Video Surveillance Market by Image Sensor, Lens, Image Processing, Analog, IP Camera, Dome, PTZ, Box …

Champion Safe Company Accelerates Market Growth with Strategic Dealer Expansion in Colorado

Champion Safe Company Accelerates Market Growth with Strategic Dealer Expansion in Colorado

New Leadership at Champion Safe, a Division of American Rebel Holdings, Inc. (NASDAQ: AREB), Crystallizes Strategic Vision for Market Share Growth Across Patriotic-Branded Divisions PROVO, UT, July 17, 2025 (GLOBE NEWSWIRE) -- Champion Safe Company (www. …

Enterprise Wired Applauds the Valuable Contributions of Derek Bryson Park in Business Leadership

Enterprise Wired Applauds the Valuable Contributions of Derek Bryson Park in Business Leadership

New York , July 17, 2025 (GLOBE NEWSWIRE) -- Enterprise Wired, a premier B2B digital publication, is proud to spotlight the influential journey of Derek Bryson Park, Principal of Wilmington Capital, through a series of articles that celebrate the …

Kratos and Intelsat Successfully Demonstrate 5G NTN Over GEO

Kratos and Intelsat Successfully Demonstrate 5G NTN Over GEO

SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Kratos Defense …

BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes

POMPANO BEACH, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, comments on the …

Announcement of Q2 2025 Financial Results  on Thursday, July 31, after market close

Announcement of Q2 2025 Financial Results on Thursday, July 31, after market close

Paris, France – July 17, 2025 Q2 2025 financial results and conference call Viridien will announce its second quarter 2025 results on Thursday, July 31, after market close. The press release and presentation will be made available on www.viridiengroup.com …

Publication des résultats financiers du T2 2025 le jeudi 31 juillet après bourse

Publication des résultats financiers du T2 2025 le jeudi 31 juillet après bourse

Paris, France – 17 juillet 2025 Résultats financiers du T2 2025 et conférence téléphonique Viridien annoncera ses résultats du 2ème trimestre 2025 le jeudi 31 juillet après bourse. Le communiqué de presse et la présentation seront disponibles sur le site …

Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories

Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories

€7.5 million upfront, with total potential development and commercial milestones, depending on Denali trial results, of up to €191.5 million Tiered royalties of up to 20% in the U.S., starting at a minimum of 8%, with tiered high single to double digit …

Nicox et Kowa signent un accord clé pouvant atteindre jusqu’à 191,5 millions d’euros pour les droits exclusifs du traitement du glaucome NCX 470 aux Etats-Unis et dans l’ensemble des territoires non-licenciés

Nicox et Kowa signent un accord clé pouvant atteindre jusqu’à 191,5 millions d’euros pour les droits exclusifs du traitement du glaucome NCX 470 aux Etats-Unis et dans l’ensemble des territoires non-licenciés

17 juillet 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui la signature d’un nouvel accord majeur …

Aalberts N.V.: Aalberts enhances hydronic flow control position in North America

Aalberts N.V.: Aalberts enhances hydronic flow control position in North America

Utrecht, 17 July 2025 Aalberts N.V. has reached an agreement to acquire 100% of the shares of Geo-Flo Corporation (Geo-Flo), based in Indiana (USA), generating an annual revenue of approximately USD 15 million with over 25 employees. Geo-Flo designs and …

Publicis Groupe : First Half 2025 Results

Publicis Groupe : First Half 2025 Results

Very strong Q2 at +5.9% organic growth Upgrading guidance thanks to new business track record July 17, 2025 Stronger-than-expected Q2 with +10% revenue growth, leading to +5.9% net revenue organic growth Accelerating ahead of +4.9% 5-year CAGR for Q2 …

Publicis Groupe : Résultats du premier semestre 2025

Publicis Groupe : Résultats du premier semestre 2025

Très forte croissance organique au T2 à +5,9 % Relèvement de la guidance grâce à des gains records de budgets 17 juillet 2025 T2 au-delà des attentes avec un revenu en hausse de +10 %, conduisant à une croissance organique du revenu net de +5,9 % En …

Press Release: Sanofi announces extension of Blueprint tender offer

Press Release: Sanofi announces extension of Blueprint tender offer

Sanofi announces extension of Blueprint tender offer Paris, July 17, 2025. Sanofi today announces that Rothko Merger Sub, Inc., a wholly owned subsidiary of Sanofi, has extended the expiration date of its tender offer to purchase all of the outstanding …

Communiqué de presse : Sanofi annonce la prolongation de l’offre publique d’achat sur Blueprint

Communiqué de presse : Sanofi annonce la prolongation de l’offre publique d’achat sur Blueprint

Sanofi annonce la prolongation de l’offre publique d’achat sur Blueprint Paris, le 17 juillet 2025. Sanofi annonce aujourd'hui que Rothko Merger Sub, Inc., une filiale détenue à 100 % par Sanofi, a prolongé la date d'expiration de son offre publique d' …

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

ZURICH, SWITZERLAND, July 17, 2025 -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp.,  a Cayman Islands exempted company and special purpose acquisition company targeting …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service